dodd-aconsensus-2011.pdf (173.17 kB)
Download file

A consensus statement for safety monitoring guidelines of treatments for major depressive disorder

Download (173.17 kB)
journal contribution
posted on 2011-09-01, 00:00 authored by Seetal DoddSeetal Dodd, G Malhi, J Tiller, I Schweitzer, I Hickie, J Khoo, D Bassett, B Lyndon, P Mitchell, G Parker, P Fitzgerald, M Udina, Ajeet SinghAjeet Singh, Steve MoylanSteve Moylan, F Giorlando, C Doughty, C Davey, M Theodoros, Michael BerkMichael Berk
Objective: This paper aims to present an overview of screening and safety considerations for the treatment of clinical depressive disorders and make recommendations for safety monitoring.
Method: Data were sourced by a literature search using MEDLINE and a manual search of scientific journals to identify relevant articles. Draft guidelines were prepared and serially revised in an iterative manner until all co-authors gave final approval of content.
Results: Screening and monitoring can detect medical causes of depression. Specific adverse effects associated with antidepressant treatments may be reduced or identified earlier by baseline screening and agent-specific monitoring after commencing treatment.
Conclusion: The adoption of safety monitoring guidelines when treating clinical depression is likely to improve overall physical health status and treatment outcome. It is important to implement these guidelines in the routine management of clinical depression.

History

Journal

Australian and New Zealand journal of psychiatry

Volume

45

Issue

9

Pagination

712 - 725

Publisher

Sage Publications

Location

London, England

ISSN

0004-8674

Language

eng

Publication classification

C1 Refereed article in a scholarly journal

Copyright notice

2011, Sage